drugset / Trial / NCT05525780
Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
This study is to evaluate the safety and tolerability of single dose of GB-5001 (donepezil) IM depot in healthy male volunteers. And, it is to predict the multiple-dose pharmacokinetics based on the single-dose pharmacokinetics of GB-5001 IM depot and the oral Aricept® (donepezil hydrochloride) tablet by PK modeling.
Timeline
- Start
- 2022-08-26
- Primary completion
- 2023-06-02
- Completion
- 2023-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 10 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 70 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 140 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 280 mg | Intramuscular |